# Innervace, Inc. — Form D

Innervace, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-22. The offering totals $40.0M, of which $10.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-08-22
- Form: D
- Accession: 0001879785-22-000062
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $40.0M
- Amount sold: $10.0M
- Remaining: $30.0M
- Investors: 7
- Date of first sale: 2022-08-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-456567

## Issuer

- Name: Innervace, Inc.
- CIK: 0001941327
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 345 PARK AVENUE SOUTH, NEW YORK, NY, 10010
- Phone: 202-352-7637

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| David Greenwald | Director | New York, NY |
| Nader Halim | Director | New York, NY |
| Jonathan Leff | Director | Ness Ziona, L3 |
| Althea Stillman | Director | New York, NY |
| Nader Halim | Executive Officer | New York, NY |
| Althea Stillman | Executive Officer | New York, NY |

## More

- [CIK 1941327 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1941327&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001879785-22-000062.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.